🩸Today's question! See the answer and explanation on the next slide.

#Hematology #FanconiAnemia #FA #BoneMarrowFailure #InheritedBoneMarrowFailure #HCT #StemCellTransplant #ConditioningRegimen #Cyclophosphamide #TransplantMedicine #PediatricHematology #HEMEHUB

Cyclosporin-Cyclophosphamide Performs Well for GVHD Prevention After Transplant | ASH Clinical News | American Society of Hematology

Patients who received #cyclosporin and #cyclophosphamide for #GVHD prevention after #HCT had improved outcomes compared to those receiving the standard cyclosporin and #methotrexate, with a median GRFS of 26.2 months vs. 6.4 months: ow.ly/pOA250WXckE #HemeSky #HemeOnc

Combination #Cyclophosphamide and #Rituximab to Minimize #Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis #ANCA

#VisualAbstract by @KajareeG

www.kireports.org/ar...

Minimizing Glucocorticoid Use in Patients With ANCA-Associated Vasculitis | Docwire News A study found that combination cyclophosphamide and rituximab therapy for severe ANCA-associated vasculitis to minimize glucocorticoid use may reduce morbidity.

Cyclophosphamide-rituximab therapy and minimal use of glucocorticoids in ANCA-associated vasculitis may reduce morbidity. #AAV #ANCAvasculitis #nephrology #rituximab #cyclophosphamide #glucocorticoids www.docwirenews.com/post/minimiz...

Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome Cyclophosphamide and infliximab are recommended as induction therapies for severe Behçet’s syndrome. Whether infliximab is safer and more effective than cyclophosphamide in treating severe Behçet’s...

📌Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome

Induction therapy with #infliximab had a superior complete response rate at 22 weeks and fewer adverse events than induction with #cyclophosphamide

#behçet @nejm.org

evidence.nejm.org/doi/full/10....